C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2001
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407893A1 New gtpase-activating protein 1
11/08/2001	CA2407887A1 Natrium-calcium exchanger protein
11/08/2001	CA2407881A1 Vectors for ocular transduction and use thereof for genetic therapy
11/08/2001	CA2407834A1 Method of identifying agents that alter the activity of the promoter sequence for corticotropin releasing-factor receptor crf 2-alpha
11/08/2001	CA2407781A1 Ceruloplasmin and uses thereof in neurodegenerative related conditions
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses
11/08/2001	CA2407696A1 Isolation of mesenchymal stem cells and use thereof
11/08/2001	CA2407695A1 Methods for binding an exogenous molecule to cellular chromatin
11/08/2001	CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407601A1 Novel human phospholipase c delta 5
11/08/2001	CA2407595A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	CA2407396A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots
11/08/2001	CA2407225A1 Methods of producing membrane vesicles
11/08/2001	CA2407219A1 Pain signaling molecules
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2406743A1 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	CA2405363A1 Epitope synchronization in antigen presenting cells
11/08/2001	CA2404937A1 Method for in vitro selection of potato clones resistant to blackspot bruising and the potatoes produced therefrom
11/08/2001	CA2403901A1 29 human secreted proteins
11/08/2001	CA2377877A1 Immunoglobulin bonding protein arrays in plant cells
11/07/2001	EP1152243A1 DIagnosis of Sjögren's syndrome, systemic lupus erythematosis, and scleroderma via detection of anti-retroviral antibodies
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152053A2 Method and apparatus for the preparation of a vascularized bioartificial tissue
11/07/2001	EP1152012A1 Tuberculosis vaccine and peptides
11/07/2001	EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus
11/07/2001	EP1151304A2 METHOD OF IDENTIFYING N-TERMINAL proBNP
11/07/2001	EP1151156A2 Luciferase reporter bioassay of parathyroid hormone compounds
11/07/2001	EP1151126A1 Biocatalytic synthesis of shikimic acid
11/07/2001	EP1151124A1 Gene repair involving in vivo excision of targeting dna
11/07/2001	EP1151123A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
11/07/2001	EP1151120A1 Inducible expression system for use in plants
11/07/2001	EP1151114A2 Metalloproteases of the neprilysin family
11/07/2001	EP1151113A2 Human peptidases
11/07/2001	EP1151109A1 Fucosyl transferase gene
11/07/2001	EP1151107A1 Basb059 polypeptides from neisseria meningitidis
11/07/2001	EP1151106A2 Methods for producing polypeptides in fungal cells
11/07/2001	EP1151102A1 Glycosylated leptin compositions and related methods
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1151091A1 Improved helper dependent vector system for gene therapy
11/07/2001	EP1151088A1 Improved phytases
11/07/2001	EP1151085A2 Nucleic acid molecules encoding alternansucrase
11/07/2001	EP1151082A1 Sebocytes, sebocyte cell lines and applications thereof
11/07/2001	EP1151081A2 Materials and methods for the modification of isoprenoid content, composition and metabolism
11/07/2001	EP1151080A2 Anti-transforming growth factor beta (tgf- beta) treated stem cell composition and method
11/07/2001	EP1151079A1 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1151011A1 Anti-ccr1 antibodies and methods of use therefor
11/07/2001	EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals
11/07/2001	EP1151009A2 Antimicrobial/endotoxin neutralizing polypeptide
11/07/2001	EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
11/07/2001	EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
11/07/2001	EP1150694A1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
11/07/2001	EP1150688A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
11/07/2001	EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone
11/07/2001	EP0986635A4 Embryonic stem cell serum replacement
11/07/2001	EP0980205A4 Method of treating malignancies
11/07/2001	EP0912901B1 Method and reagent for monitoring blood levels of antiplatelet compounds
11/07/2001	EP0783693B1 In vitro models of cns function and dysfunction
11/07/2001	EP0731632B1 Agrobacterium tumefaciens transformation of musa species
11/07/2001	EP0689596B1 Stimulation of immune response by viral protein
11/07/2001	EP0651768B1 USE OF p97 IN THE DIAGNOSIS OF ALZHEIMER DISEASE
11/07/2001	CN1321199A Cell lines for propagation of mutated herpes viruses
11/07/2001	CN1321197A New salicylic acid inducible genes and promoters from tobacco
11/07/2001	CN1321194A Transgenic amorpha-4,11-diene synthesis
11/07/2001	CN1321193A RNA virus vector having contact infiltration capability
11/07/2001	CN1321191A Pi-ta gene conferring disease resistance to plants
11/07/2001	CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
11/07/2001	CN1321167A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of HLA
11/07/2001	CN1321165A Prevention and treatment of viral disease
11/07/2001	CN1321093A Method to enhance and confine expression of genes
11/07/2001	CN1321064A Plant resistance to insect pests medicated by viral proteins
11/07/2001	CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/06/2001	US6313373 Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
11/06/2001	US6313369 Wound healing agents
11/06/2001	US6313280 Suppresses brachyury-mediated transcription activation; hybrid screening assays; zinc finger domains; genetic engineering and expression
11/06/2001	US6313276 Human endothelin receptor
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313102 Stabilized dry composition comprising therapeutic agent susceptible to maillard reaction, further comprising reducing carbohydrate as stabilizer for therapeutic agent and inhibitor of maillard reaction
11/06/2001	US6312957 Genetic modification of primate hemopoietic repopulating stem cells
11/06/2001	US6312952 In vitro cell culture device including cartilage and methods of using the same
11/06/2001	US6312951 Expression augmenting sequence elements (ease) for eukaryotic expression systems
11/06/2001	US6312950 Isolating and recovering cells; feed sample through filter and recover confined cells from filter
11/06/2001	US6312948 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells
11/06/2001	US6312936 Enzymatic polypeptide for use in the treatment of animal feeds and textiles
11/06/2001	US6312933 Carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
11/06/2001	US6312922 Complementary DNAs
11/06/2001	US6312921 Nucleotide sequences which code preferential polyeptides; for use in diagnosis and treatment of tumors
11/06/2001	US6312912 Detecting regulatory preferential sequences; measure expression of heterologous nucleotide sequence in presence and absence of preferential regulatory sequences, compare to control, amplified expression indicates regulatory sequences
11/06/2001	US6312910 Multistage electromagnetic separator for purifying cells, chemicals and protein structures
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals

1 ... 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 ... 1827